Global Next Generation Immunotherapies Market Revenue and CAGR Forecast Analysis 2025–2029
Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.
What Are The Future Growth Projections For The Next Generation Immunotherapies Market Size?
The market size of next generation immunotherapies has seen a swift expansion in recent years. Starting from $133.81 billion in 2024, it is expected to reach $150.12 billion in 2025, with a compound annual growth rate (CAGR) of 12.2%. Factors like the growing occurrence of oncology cases, increased investments in research and development, a surge in governmental initiatives, an upward trend in governmental health expenditure, and widening indications have contributed to this significant growth in the historic period.
The market size of next-generation immunotherapies is anticipated to surge significantly in the upcoming years, with an expected valuation of $235.85 billion in 2029 and a compound annual growth rate (CAGR) of 12.0%. This projected expansion during the forecast period is linked to factors such as the escalating prevalence of cancer, increased healthcare spending, wider acceptance of chimeric antigen receptor (CAR) T-cell therapy, greater burden of chronic diseases, and intensified drug research on the next generation. The forecast period will also witness several key trends such as the inclination towards combined therapies, technological advances, innovative therapeutic strategies, progress in personalized medicine, and advancements in regulatory support.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21231&type=smp
Which Demand Drivers Are Strengthening The Next Generation Immunotherapies Market?
The escalating incidence of cancer is forecasted to stimulate the Next-Generation Immunotherapies Market’s expansion. Cancer refers to a class of diseases distinguished by uncontrolled abnormal cell growth and dispersion within the body. The aging population, lifestyle shifts, environmental exposures, and improved detection techniques contribute to the increased occurrence of cancer. Next-generation immunotherapies offer superior, targeted treatments that amplify the body’s immune reaction against cancer. These treatments offer enhanced efficacy, durability, and personalization. For example, the National Cancer Institute (NCI), a government agency based in the United States, shared reports in May 2024 revealing that, in 2022, around 20 million new cancer cases and 9.7 million cancer-related fatalities were documented globally. Furthermore, it is projected that by 2040, there will be 29.9 million new cases and 15.3 million cancer-related deaths. Consequently, the rising incidence of cancer is fueling the growth of the Next-Generation Immunotherapies Market.
What Segmentation Insights Are Provided In The Next Generation Immunotherapies Market Research?
The next generation immunotherapiesmarket covered in this report is segmented –
1) By Drug Class: Monoclonal Antibodies; Antibody-Drug Conjugates – ADC’s; Angiotensin-Converting Enzyme (ACE) Inhibitors; Immune Checkpoint Inhibitors
2) By Route Of Administration: Intravenous; Parenteral; Intratumoral; Subcutaneous; Oral
3) By Distribution Channel: Hospital Pharmacies; Clinical Pharmacies; Other Distribution channels
Subsegments:
1) By Monoclonal Antibodies: Anti-PD-1 Antibodies; Anti-PD-L1 Antibodies; Anti-CTLA-4 Antibodies; Anti-CD20 Antibodies; Other Monoclonal Antibodies
2) By Antibody-Drug Conjugates (ADC’s): HER2-targeted ADCs; CD30-targeted ADCs; CD19-targeted ADCs; Other ADCs
3) By Angiotensin-Converting Enzyme (ACE) Inhibitors: ACE Inhibitors For Cancer Therapy; ACE Inhibitors For Other Indications
4) By Immune Checkpoint Inhibitors: PD-1 Or PD-L1 Inhibitors; CTLA-4 Inhibitors; Other Immune Checkpoint Inhibitors
Which Trends Are Likely To Redefine Growth Paths In The Next Generation Immunotherapies Market?
Key players in the next-generation immunotherapies market are developing innovative therapies such as CAR T-cell therapy for cancers, autoimmune, and infectious diseases. CAR T-cell therapy involves genetically engineering a patient’s T cells to express chimeric antigen receptors (CARs) that target cancer cells. For example, in January 2025, Immuneel Therapeutics Private Limited, an Indian cell and gene therapy startup, launched Qartemi, India’s first CAR T-cell therapy for adult B-cell non-Hodgkin lymphoma. This therapy modifies immune cells to target and destroy cancer, offering a personalized and effective treatment option that is more affordable than comparable global therapies.
Which Firms Are Driving Innovation Within The Next Generation Immunotherapies Market?
Major companies operating in the next generation immunotherapies market are Pfizer Inc., F. Hoffmann-La Roche Ltd., Merck & Co. Inc., AbbVie Inc., Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca PLC, Novartis AG, GlaxoSmithKline plc (GSK), Eli Lilly and Company, Gilead Sciences Inc., Amgen Inc., Boehringer Ingelheim International GmbH, Regeneron Pharmaceuticals Inc., Incyte Corporation, BioNTech SE, Xencor Inc., Fate Therapeutics Inc., Immatics N.V., Atara Biotherapeutics Inc., Menarini Group, Alpine Immune Sciences Inc., Mereo Biopharma Group plc, Immunomic Therapeutics Inc., Indaptus Therapeutics Inc.
Access The Complete Report Here:
Which Regional Markets Are Emerging As Key Hubs For The Next Generation Immunotherapies Market?
North America was the largest region in the next-generation immunotherapies market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the next generation immunotherapies market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=21231&type=smp
Browse Through More Reports Similar to the Global Next Generation Immunotherapies Market 2025, By The Business Research Company
Clinical Oncology Next Generation Sequencing Global Market Report 2025
Next Generation Sequencing Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/next-generation-sequencing-global-market-report
Next Generation Military Power Supply Global Market Report 2025
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
